These data showed that over-expressing miR-125a-5p inhibited NSCLC development in vivo through suppressing Suv39H1 expression, resulting in endogenous miR-125a-5p demethylation and upregulation. The gene discussed is SUV39H1; the disease is non-small cell lung carcinoma.